MXPA02001936A - Tratamiento mixto con una variante de activador de plasminogeno tisular y heparina de peso molecular bajo. - Google Patents
Tratamiento mixto con una variante de activador de plasminogeno tisular y heparina de peso molecular bajo.Info
- Publication number
- MXPA02001936A MXPA02001936A MXPA02001936A MXPA02001936A MX PA02001936 A MXPA02001936 A MX PA02001936A MX PA02001936 A MXPA02001936 A MX PA02001936A MX PA02001936 A MXPA02001936 A MX PA02001936A
- Authority
- MX
- Mexico
- Prior art keywords
- variant
- low weight
- tissue plasminogen
- weight heparin
- plasminogen activator
- Prior art date
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002897 heparin Drugs 0.000 title abstract 2
- 229920000669 heparin Polymers 0.000 title abstract 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 title 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 title 1
- 229960000187 tissue plasminogen activator Drugs 0.000 title 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 230000002537 thrombolytic effect Effects 0.000 abstract 2
- 102000009123 Fibrin Human genes 0.000 abstract 1
- 108010073385 Fibrin Proteins 0.000 abstract 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 1
- 101000801481 Homo sapiens Tissue-type plasminogen activator Proteins 0.000 abstract 1
- 102000001938 Plasminogen Activators Human genes 0.000 abstract 1
- 108010001014 Plasminogen Activators Proteins 0.000 abstract 1
- 206010000891 acute myocardial infarction Diseases 0.000 abstract 1
- 229950003499 fibrin Drugs 0.000 abstract 1
- 102000047823 human PLAT Human genes 0.000 abstract 1
- 229940127126 plasminogen activator Drugs 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invencion se relaciona con un regimen mejorado para el tratamiento de trastornos tromboliticos tales como infarto agudo al miocardio (IAM). En particular, la presente invencion se relaciona con el tratamiento de trastornos tromboliticos, por ejemplo IAM, con una combinacion de una variante de activador de plasminogeno tisular (t-PA) que tiene especificidad mejorada por fibrina y una vida media en plasma prolongada, cuando se compara con t-PA humano de tipo silvestre, y una heparina de peso molecular bajo.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA02001936 MXPA02001936A (es) | 2002-02-22 | 2002-02-22 | Tratamiento mixto con una variante de activador de plasminogeno tisular y heparina de peso molecular bajo. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA02001936 MXPA02001936A (es) | 2002-02-22 | 2002-02-22 | Tratamiento mixto con una variante de activador de plasminogeno tisular y heparina de peso molecular bajo. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02001936A true MXPA02001936A (es) | 2004-08-12 |
Family
ID=34567948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02001936 MXPA02001936A (es) | 2002-02-22 | 2002-02-22 | Tratamiento mixto con una variante de activador de plasminogeno tisular y heparina de peso molecular bajo. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MXPA02001936A (es) |
-
2002
- 2002-02-22 MX MXPA02001936 patent/MXPA02001936A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL350042A1 (en) | Serine protease inhibitors | |
| IL147317A0 (en) | NITROGEN CONTAINING HETEROBICYCLES AS FACTOR Xa INHIBITORS | |
| DK1232254T3 (da) | Fremgangsmåde til fremstilling af en reversibelt inaktiv syrnet plasminkomponent | |
| AU2002302564A1 (en) | Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants | |
| MXPA02002901A (es) | Enzimas de ruta de enfocado lisosomal. | |
| AU2002360488A1 (en) | Methods and devices for detection and therapy of atheromatous plaque | |
| ES2018729A6 (es) | Un metodo para preparar una variante de activador de plasmogeno de tejido. | |
| EP1825864A3 (en) | Antithrombotic agents | |
| ATE260246T1 (de) | Selektive inhibitoren des urokinase-plasminogen aktivators | |
| WO2003079978A3 (en) | Protease activity of thrombin inhibits angiogenesis | |
| MXPA02001936A (es) | Tratamiento mixto con una variante de activador de plasminogeno tisular y heparina de peso molecular bajo. | |
| WO2002002519A3 (en) | THROMBIN OR FACTOR Xa INHIBITORS | |
| Doctor et al. | Effect of fucoidan during activation of human plasminogen | |
| EP1505079A3 (de) | Heparin mit mittlerer Molmasse von 10 bis 11,5 kD | |
| WO2003053999A3 (de) | Selektive arylguanidinpeptide als urokinaseinhibitoren | |
| WO1998021320A3 (en) | Tissue type plasminogen activator (t-pa) variants: compositions and methods of use | |
| BR0200596A (pt) | Método de tratamento por meio de uma combinação de uma variante ativadora de plasminogênio de tecido (t-pa) e uma heparina de baixo peso molecular e uso da mesma | |
| WO2001024784A3 (en) | New use | |
| AR032843A1 (es) | Tratamiento de combinacion con variante de t-pa y heparina de bajo peso molecular | |
| WO2003095476A3 (en) | PEPTIDES FOR REGULATION OF UROKINASE (uPA) AND TISSUE TYPE (tPA) PLASMINOGEN ACTIVATOR AND METHOD OF OPTIMIZING THERAPEUTIC EFFICACY | |
| Hryszko et al. | Activated protein C enhances tPA-catalyzed Glu-plasminogen activation in the presence of poly-D-lysine | |
| IL129332A0 (en) | suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status |
Owner name: BAYER CROPSCIENCE AG.* |
|
| FA | Abandonment or withdrawal |